Insider Trading History of Shih Alvin

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Shih Alvin since 2015. This trader's CIK number is 1610064. At the time of last reporting, Shih Alvin was the Director of Zevra Therapeutics, Inc.. (stock ticker symbol ZVRA). Also see all insider trading activities at Zevra Therapeutics, Inc..

Note that in the past Shih Alvin also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Zevra Therapeutics, Inc. (ZVRA) by Shih Alvin

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 ZVRA 20,000 $157,800 0 $0 0 $0

Yearly summary of insider trading at Travere Therapeutics, Inc. (RTRX) by Shih Alvin

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 RTRX 0 $0 17,500 $297,342 0 $0
2015 RTRX 0 $0 45,416 $1,274,901 0 $0


Insider trading activities at 2 companies by Shih Alvin:

1. Zevra Therapeutics, Inc. (ZVRA)

2. Travere Therapeutics, Inc. (RTRX)

Table 1. Insider trading of Zevra Therapeutics, Inc. (ZVRA) by Shih Alvin

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-09-12 ZVRA Buy 20,000 7.89 157,800

Table 2. Insider trading of Travere Therapeutics, Inc. (RTRX) by Shih Alvin

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-09-01 RTRX Sale 8,750 16.23 142,056
2016-06-01 RTRX Sale 8,750 17.75 155,286
2015-12-09 RTRX Sale 8,750 20.83 182,262
2015-10-06 RTRX Sale 8,750 20.55 179,786
2015-06-26 RTRX Sale 27,916 32.70 912,853

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shih Alvin (Director of Zevra Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.